Cargando…

Prognostic marker and target in prostate cancer

Detalles Bibliográficos
Autores principales:	Lavorgna, Giovanni, Montorsi, Francesco, Salonia, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4637200/ https://www.ncbi.nlm.nih.gov/pubmed/26525159

Ejemplares similares

Expression-profiling of apoptosis induced by ablation of the long ncRNA TRPM2-AS in prostate cancer cell
por: Lavorgna, Giovanni, et al.
Publicado: (2014)

Sexual dysfunction and prostate cancer risk: one more piece of a complex puzzle
por: Capogrosso, Paolo, et al.
Publicado: (2017)

Endoplasmic reticulum oxidoreductase 1 alpha modulates prostate cancer hallmarks
por: Cornelius, Julian, et al.
Publicado: (2021)

Single-cell transcriptome profiling reveals several LncRNAs differentially expressed in idiopathic germ cell aplasia
por: Lavorgna, Giovanni, et al.
Publicado: (2022)

A virus-free cellular model recapitulates several features of severe COVID-19
por: Lavorgna, Giovanni, et al.
Publicado: (2021)

A mechanistic insight into the anti-metastatic role of the prostate specific antigen
por: Pellegrino, Francesco, et al.
Publicado: (2021)

Mini Review on the Use of Clinical Cancer Registers for Prostate Cancer: The National Prostate Cancer Register (NPCR) of Sweden
por: Cazzaniga, Walter, et al.
Publicado: (2019)

Urine Endocannabinoids as Novel Non-Invasive Biomarkers for Bladder Cancer at Early Stage
por: Vago, Riccardo, et al.
Publicado: (2020)

Early diagnosis of bladder cancer by photoacoustic imaging of tumor-targeted gold nanorods
por: Alchera, Elisa, et al.
Publicado: (2022)

Focal therapy for prostate cancer – index lesion treatment vs. hemiablation. A matter of definition
por: Stabile, Armando, et al.
Publicado: (2019)

Postprostatectomy Erectile Dysfunction: A Review
por: Capogrosso, Paolo, et al.
Publicado: (2016)

The interplay of extracellular matrix and microbiome in urothelial bladder cancer
por: Alfano, Massimo, et al.
Publicado: (2015)

Prognostic markers for colorectal cancer
por: Tyrrell, Helen E.J., et al.
Publicado: (2018)

Multiple PDE5Is use as a marker of decreased overall men’s health: A real-life study
por: Oreggia, Davide, et al.
Publicado: (2018)

Orgasmic Dysfunction after Radical Prostatectomy
por: Capogrosso, Paolo, et al.
Publicado: (2017)

Diagnostic and Prognostic Markers in Bladder Cancer
por: Ku, Ja Hyeon, et al.
Publicado: (2016)

The Mediterranean Diet as a Source of Bioactive Molecules with Cannabinomimetic Activity in Prevention and Therapy Strategy
por: Vago, Riccardo, et al.
Publicado: (2022)

Bladder cancer cell growth and motility implicate cannabinoid 2 receptor-mediated modifications of sphingolipids metabolism
por: Bettiga, Arianna, et al.
Publicado: (2017)

New Prognostic and Predictive Markers in Cancer Progression
por: Costantini, Susan, et al.
Publicado: (2020)

New Prognostic and Predictive Markers in Head and Neck Tumors
por: Cantile, Monica, et al.
Publicado: (2016)

Prevention and management of post prostatectomy erectile dysfunction
por: Salonia, Andrea, et al.
Publicado: (2015)

How to Prevent and Manage Post-Prostatectomy Incontinence: A Review
por: Schifano, Nicolò, et al.
Publicado: (2021)

Long-term recovery of normal sexual function in testicular cancer survivors
por: Capogrosso, Paolo, et al.
Publicado: (2016)

Galectins as New Prognostic Markers and Potential Therapeutic Targets for Advanced Prostate Cancers
por: Laderach, Diego J., et al.
Publicado: (2013)

Advances in Prostate Cancer Research and Treatment
por: Livi, Lorenzo, et al.
Publicado: (2014)

Is erectile dysfunction a reliable indicator of general health status in men?
por: Salonia, Andrea, et al.
Publicado: (2013)

New targets for resistant prostate cancer
por: Thompson, Timothy C., et al.
Publicado: (2014)

Ampullary carcinoma prognostic markers
por: Perkins, Geraldine, et al.
Publicado: (2019)

Prognostic DNA Methylation Markers for Prostate Cancer
por: Strand, Siri H., et al.
Publicado: (2014)

VAV2: a novel prognostic marker and a druggable target for adrenocortical carcinoma
por: Ruggiero, Carmen, et al.
Publicado: (2017)

Gene Expression and DNA Methylation as Prognostic Markers in Metastatic Castration-Resistant Prostate Cancer: Analysis of Circulating Tumor Cells and Paired Plasma-Derived Exosomes
por: Hussein, Mohamed Ali, et al.
Publicado: (2023)

Evaluating the role of neoadjuvant chemotherapy in bladder cancer patients with occult lymph node metastases
por: Moschini, Marco, et al.
Publicado: (2018)

Targeting protein myristoylation for the treatment of prostate cancer
por: Sulejmani, Essilvo, et al.
Publicado: (2018)

Diagnostic and Prognostic Markers in Liver Cirrhosis
por: Augustin, Salvador, et al.
Publicado: (2011)

Molecular markers as therapeutic targets in lung cancer
por: Tseng, Hsin-Hui, et al.
Publicado: (2013)

Inflammation is a target of medical treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia
por: De Nunzio, Cosimo, et al.
Publicado: (2020)

Effectiveness and cost-effectiveness of prognostic markers in prostate cancer
por: Calvert, N W, et al.
Publicado: (2003)

Correction to: Inflammation is a target of medical treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia
por: De Nunzio, Cosimo, et al.
Publicado: (2020)

Oligometastatic prostate cancer: is it worth targeting the tip of the iceberg?
por: Supiot, Stéphane, et al.
Publicado: (2019)

Prostate Cancer: Is There Still a Role for Systematic Biopsies? Yes
por: Gandaglia, Giorgio, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v9k2a3k4q0q2f0np2nur66aatb